Characterization of alternatively spliced products and tissue-specific isoforms of USP28 and USP25

dc.contributor.author
Valero Gils, Rebeca
dc.contributor.author
Bayés Colomer, Mònica
dc.contributor.author
Sánchez-Font, Ma. Francisca
dc.contributor.author
Gonzàlez-Angulo, Olga
dc.contributor.author
Gonzàlez-Duarte, Roser
dc.contributor.author
Marfany i Nadal, Gemma
dc.date.issued
2009-03-26T08:49:54Z
dc.date.issued
2009-03-26T08:49:54Z
dc.date.issued
2001
dc.identifier
1465-6914
dc.identifier
https://hdl.handle.net/2445/7381
dc.identifier
520442
dc.identifier
11597335
dc.description.abstract
Background: The ubiquitin-dependent protein degradation pathway is essential for the proteolysis of intracellular proteins and peptides. Deubiquitinating enzymes constitute a complex protein family involved in a multitude of cellular processes. The ubiquitin-specific proteases (UBP) are a group of enzymes whose predicted function is to reverse the ubiquitinating reaction by removing ubiquitin from a large variety of substrates. We have lately reported the characterization of human USP25, a specific-ubiquitin protease gene at 21q11.2, with a specific pattern of expression in murine fetal brains and adult testis. Results: Database homology searches at the DNA and protein levels and cDNA library screenings led to the identification of a new UBP member in the human genome, named USP28, at 11q23. This novel gene showed preferential expression in heart and muscle. Moreover, cDNA, expressed sequence tag and RT-PCR analyses provided evidence for alternatively spliced products and tissue-specific isoforms. Concerning function, USP25 overexpression in Down syndrome fetal brains was shown by real-time PCR. Conclusions: On the basis of the genomic and protein sequence as well as the functional data, USP28 and USP25 establish a new subfamily of deubiquitinating enzymes. Both genes have alternatively spliced exons that could generate protein isoforms with distinct tissue-specific activity. The overexpression of USP25 in Down syndrome fetal brains supports the gene-dosage effects suggested for other UBP members related to aneuploidy syndromes.
dc.format
10 p.
dc.format
application/pdf
dc.format
application/pdf
dc.language
eng
dc.publisher
BioMed Central
dc.relation
Reproducció del document publicat a http://dx.doi.org/10.1186/gb-2001-2-10-research0043
dc.relation
Genome Biology, 2001, vol. 2, núm. 10
dc.relation
http://dx.doi.org/10.1186/gb-2001-2-10-research0043
dc.rights
cc-by, (c) Valero et al., 2001
dc.rights
http://creativecommons.org/licenses/by/2.0/
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Genètica, Microbiologia i Estadística)
dc.subject
Biologia cel·lular
dc.subject
Genètica molecular
dc.subject
Medicina
dc.subject
Neurobiologia
dc.subject
Cell biology
dc.subject
Molecular biology
dc.subject
Medicine
dc.subject
Neurobiology
dc.title
Characterization of alternatively spliced products and tissue-specific isoforms of USP28 and USP25
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)